Trial Profile
The impact of serum testosterone level as prognosis factor for CRPC with enzalutamide or Abraterone
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Abiraterone (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms PC-TES
- 30 Oct 2015 New trial record